In a broader sense, IL-23 could therefore be regarded as a rheostat of myeloid cell viability, i. e. myeloid cell presence at the site of infection, to minimize variations in myeloid cell numbers that may otherwise compromise host protection or promote immunopathology during systemic C. albicans infection. The gene discussed is IL23A; the disease is infection.